Related Experiment Video
Updated: Jun 13, 2026
11:59
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
[Thalassemia intermedia: 36 cases]
Raouf Hafsia1, Naouel Ben Salah, Emna Hafhouf
1Service d'Hématologie Biologique, Hôpital Aziza Othmana, Tunis.
La Tunisie Medicale
|April 27, 2010
Summary
Thalassemia intermedia is a mild form of thalassemia, generally well-tolerated with a good lifespan. Treatment, including transfusions and splenectomy, is typically reserved for cases with hypersplenism.
Area of Science:
- Hematology
- Genetics
Context:
- Thalassemia intermedia presents a broad clinical and biological spectrum.
- Understanding its features is crucial for effective management.
Purpose:
- To detail the clinical and biological characteristics of thalassemia intermedia.
- To outline treatment strategies and patient outcomes.
Summary:
- A retrospective study analyzed 36 thalassemia intermedia patients, diagnosing them at a median age of 15 years.
- Key features included mild anemia, splenomegaly, and varied phenotypes (heterozygosis, beta degrees, beta+).
- Complications like hypersplenism, thrombosis, and pulmonary hypertension were noted, with transfusions and splenectomy used in 47% of cases.
Impact:
- Thalassemia intermedia is generally well-tolerated, with a mean lifespan of 31 years.
- This study provides insights into the management and prognosis of this specific thalassemia type.
Related Concept Videos
01:49Multiple Allele Traits
The Concept of Multiple Allelism
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:21Hyperosmolar Hyperglycemic State
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...